Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_assertion type Assertion NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_head.
- NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_assertion description "[Triple-negative breast cancer (TNBC) is an aggressive clinical subtype of breast cancer that is characterized by the lack of estrogen receptor (ER) and progesterone receptor (PR) expression as well as human epidermal growth factor receptor 2 (HER2) overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_provenance.
- NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_assertion evidence source_evidence_literature NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_provenance.
- NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_assertion SIO_000772 24188694 NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_provenance.
- NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_assertion wasDerivedFrom befree-2016 NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_provenance.
- NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_assertion wasGeneratedBy ECO_0000203 NP1124784.RAZE9FAz2r7rDZq3KImW9re3w-F6qyAQxlTIbr2HW-GWY130_provenance.